Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.

Purpose: We previously reported that paclitaxel, a microtubule-stabilizing drug, inhibited angiogenesis, mainly by inhibiting endothelial cell motility (D. Belotti et al., Clin.